Production (Stage)
Evogene Ltd.
EVGN
$1.38
-$0.14-9.21%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | 13.00% | 12.84% | 10.36% | 34.62% |
| Total Depreciation and Amortization | -- | 1.32% | 4.02% | 1.24% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 241.12% | 195.15% | -92.18% | -60.28% |
| Change in Net Operating Assets | -- | -1,010.45% | -243.34% | 48.12% | 64.97% |
| Cash from Operations | -- | 4.07% | 12.48% | 8.87% | 39.30% |
| Capital Expenditure | -- | 47.74% | 47.89% | 32.96% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -61.54% | -61.54% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 132.99% | -425.32% | -126.16% | -120.79% |
| Cash from Investing | -- | 123.63% | -676.69% | -134.19% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -4.12% | 14.92% | 10.01% | -67.09% |
| Issuance of Common Stock | -- | 2,196.64% | 2,731.83% | 30,075.00% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.87% | 3.13% | 4.16% | 4.85% |
| Cash from Financing | -- | -64.88% | 86.73% | 94.28% | 86.98% |
| Foreign Exchange rate Adjustments | -- | 107.73% | 91.01% | 89.27% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -24.50% | 14.82% | -145.38% | 21.55% |